EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 178 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $585,000 | -64.3% | 6,524 | -58.8% | 0.09% | -71.1% |
| Q3 2020 | $1,637,000 | -68.9% | 15,847 | -76.2% | 0.32% | -70.4% |
| Q2 2020 | $5,272,000 | +149.1% | 66,662 | +82.3% | 1.08% | +98.9% |
| Q1 2020 | $2,116,000 | +34.0% | 36,573 | +21.9% | 0.54% | +332.8% |
| Q1 2018 | $1,579,000 | -38.2% | 30,000 | -45.5% | 0.12% | -33.2% |
| Q4 2017 | $2,556,000 | -21.0% | 55,000 | -31.2% | 0.19% | -14.2% |
| Q3 2017 | $3,236,000 | +19.3% | 80,000 | 0.0% | 0.22% | +35.4% |
| Q2 2017 | $2,713,000 | +69.9% | 80,000 | +45.5% | 0.16% | +101.2% |
| Q1 2017 | $1,597,000 | +47.3% | 55,000 | +66.7% | 0.08% | +60.0% |
| Q4 2016 | $1,084,000 | – | 33,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
| Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
| GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
| Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
| GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
| LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
| TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
| TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
| NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |